These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36508580)

  • 1. Phosphoproteomic Analysis of Dopamine D2 Receptor Signaling Reveals Interplay of G Protein- and β-Arrestin-Mediated Effects.
    Wenk D; Khan S; Ignatchenko V; Hübner H; Gmeiner P; Weikert D; Pischetsrieder M; Kislinger T
    J Proteome Res; 2023 Jan; 22(1):259-271. PubMed ID: 36508580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionally selective activation of the dopamine receptor D
    Wenk D; Ignatchenko V; Macklin A; Hübner H; Gmeiner P; Weikert D; Pischetsrieder M; Kislinger T
    Sci Rep; 2021 Feb; 11(1):3501. PubMed ID: 33568753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor, Ligand and Transducer Contributions to Dopamine D2 Receptor Functional Selectivity.
    Peterson SM; Pack TF; Caron MG
    PLoS One; 2015; 10(10):e0141637. PubMed ID: 26516769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells.
    Luessen DJ; Hinshaw TP; Sun H; Howlett AC; Marrs G; McCool BA; Chen R
    Neuropharmacology; 2016 Nov; 110(Pt A):297-307. PubMed ID: 27528587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered D2R Variants Reveal the Balanced and Biased Contributions of G-Protein and β-Arrestin to Dopamine-Dependent Functions.
    Rose SJ; Pack TF; Peterson SM; Payne K; Borrelli E; Caron MG
    Neuropsychopharmacology; 2018 Apr; 43(5):1164-1173. PubMed ID: 29068002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor.
    Peterson SM; Pack TF; Wilkins AD; Urs NM; Urban DJ; Bass CE; Lichtarge O; Caron MG
    Proc Natl Acad Sci U S A; 2015 Jun; 112(22):7097-102. PubMed ID: 25964346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulation of biased agonists at the dopamine D2 receptor suggests the mechanism of receptor functional selectivity.
    Montgomery D; Campbell A; Sullivan HJ; Wu C
    J Biomol Struct Dyn; 2019 Aug; 37(12):3206-3225. PubMed ID: 30124143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.
    Masri B; Salahpour A; Didriksen M; Ghisi V; Beaulieu JM; Gainetdinov RR; Caron MG
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13656-61. PubMed ID: 18768802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Functional Selectivity Relationship Studies on A-86929 Analogs and Small Aryl Fragments toward the Discovery of Biased Dopamine D1 Receptor Agonists.
    Li H; Mirabel R; Zimmerman J; Ghiviriga I; Phidd DK; Horenstein N; Urs NM
    ACS Chem Neurosci; 2022 Jun; 13(12):1818-1831. PubMed ID: 35658399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic-Like Efficacy of Dopamine D
    Sahlholm K; Gómez-Soler M; Valle-León M; López-Cano M; Taura JJ; Ciruela F; Fernández-Dueñas V
    Mol Neurobiol; 2018 Jun; 55(6):4952-4958. PubMed ID: 28779351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation.
    Pack TF; Orlen MI; Ray C; Peterson SM; Caron MG
    J Biol Chem; 2018 Apr; 293(16):6161-6171. PubMed ID: 29487132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dopamine D2 receptor mutant capable of G protein-mediated signaling but deficient in arrestin binding.
    Lan H; Liu Y; Bell MI; Gurevich VV; Neve KA
    Mol Pharmacol; 2009 Jan; 75(1):113-23. PubMed ID: 18809670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor.
    Free RB; Chun LS; Moritz AE; Miller BN; Doyle TB; Conroy JL; Padron A; Meade JA; Xiao J; Hu X; Dulcey AE; Han Y; Duan L; Titus S; Bryant-Genevier M; Barnaeva E; Ferrer M; Javitch JA; Beuming T; Shi L; Southall NT; Marugan JJ; Sibley DR
    Mol Pharmacol; 2014 Jul; 86(1):96-105. PubMed ID: 24755247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitination of GRK2 Is Required for the β-Arrestin-Biased Signaling Pathway of Dopamine D2 Receptors to Activate ERK Kinases.
    Liu H; Ma H; Zeng X; Wu C; Acharya S; Sudan SK; Zhang X
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists.
    Chen X; McCorvy JD; Fischer MG; Butler KV; Shen Y; Roth BL; Jin J
    J Med Chem; 2016 Dec; 59(23):10601-10618. PubMed ID: 27805392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of biased agonism at the dopamine D₂ receptor.
    Weichert D; Banerjee A; Hiller C; Kling RC; Hübner H; Gmeiner P
    J Med Chem; 2015 Mar; 58(6):2703-17. PubMed ID: 25734236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties.
    Urs NM; Gee SM; Pack TF; McCorvy JD; Evron T; Snyder JC; Yang X; Rodriguiz RM; Borrelli E; Wetsel WC; Jin J; Roth BL; O'Donnell P; Caron MG
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8178-E8186. PubMed ID: 27911814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D
    Bonifazi A; Yano H; Ellenberger MP; Muller L; Kumar V; Zou MF; Cai NS; Guerrero AM; Woods AS; Shi L; Newman AH
    J Med Chem; 2017 Apr; 60(7):2890-2907. PubMed ID: 28300398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational insights into ligand-induced G protein and β-arrestin signaling of the dopamine D1 receptor.
    Li H; Urs NM; Horenstein N
    J Comput Aided Mol Des; 2023 Jun; 37(5-6):227-244. PubMed ID: 37060492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling-Biased and Constitutively Active Dopamine D2 Receptor Variant.
    Rodriguez-Contreras D; Condon AF; Buck DC; Asad N; Dore TM; Verbeek DS; Tijssen MAJ; Shinde U; Williams JT; Neve KA
    ACS Chem Neurosci; 2021 Jun; 12(11):1873-1884. PubMed ID: 33974399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.